Mechanisms of inhibition of endothelial cell migration by taxanes

Cytoskeleton

Volumn 71, Issue 1, 2014, Pages 46-60

  Kamath, Kathy ^a   Smiyun, Greg ^a   Wilson, Leslie ^a   Jordan, Mary Ann ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Centrosome; Dynamic instability; Focal adhesion; HUVEC; Microtubule; Mitosis

Indexed keywords

DOCETAXEL; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MIGRATION; CELL STRUCTURE; CENTROSOME; CONTROLLED STUDY; DRUG MECHANISM; FOCAL ADHESION; HUMAN; HUMAN CELL; MICROTUBULE; MITOSIS; MITOSIS INHIBITION; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL; WOUND;

CENTROSOME; DYNAMIC INSTABILITY; FOCAL ADHESION; HUVEC; MICROTUBULE; MITOSIS;

CELL CULTURE TECHNIQUES; CELL MOVEMENT; CENTROSOME; ENDOTHELIAL CELLS; FOCAL ADHESIONS; HUMANS; MICROTUBULES; TAXOIDS;

EID: 84892544340     PISSN: 19493584     EISSN: 19493592     Source Type: Journal    
DOI: 10.1002/cm.21153     Document Type: Article

References (58)

1. Ballestrem C, Wehrle-Haller B, Hinz B, Imhof BA. 2000. Actin-dependent lamellipodia formation and microtubule-dependent tail retraction control-directed cell migration. Mol Biol Cell 11:2999-3012.
2. Belotti D, Vergani V, Drudis T, Borsotti P, Pitelli MR, Viale G, Giavazzi R, Taraboletti G. 1996. The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 2:1843-1849.
3. Bijman MN, van Nieuw Amerongen GP, Laurens N, van Hinsbergh VW, Boven E. 2006. Microtubule-targeting agents inhibit angiogenesis at subtoxic concentrations, a process associated with inhibition of Rac1 and Cdc42 activity and changes in the endothelial cytoskeleton. Mol Cancer Ther 5(9):2348-2357.
4. Broussard JA, Webb DJ, Kaverina I. 2008. Asymmetric focal adhesion disassembly in motile cells. Curr Opin Cell Biol 20(1):85-90.
5. Derry WB, Wilson L, Khan IA, Luduena RF, Jordan MA. 1997. Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes. Biochemistry 36:3554-3562.
6. Entschladen F, Zanker KS, Powe DG. 2000. Heterotrimeric G protein signaling in cancer cells with regard to metastasis formation. Cell Cycle 10:1086-1091.
7. Ezratty EJ, Partridge MA, Gundersen GG. 2005. Microtubule-induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase. Nat Cell Biol 7:581-590.
8. Folkman J. 2007. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6(4):273-286.
9. Gan PP, McCarroll JA, Byrne FL, Garner J, Kavallaris M. 2011. Specific β-tubulin isotypes can functionally enhance or diminish epothilone B sensitivity in non-small cell lung cancer cells. PLoS One 6(6):e21717. doi: 10.1371/journal.pone.0021717.
10. Ganguly A, Yang H, Pedroza M, Bhattacharya R, Cabral F. 2011. Mitotic centromere-associated kinesin (MCAK) mediates paclitaxel resistance. J Biol Chem 286(42):36378-36384.
11. Goncalves A, Braguer D, Kamath K, Martello L, Briand C, Horwitz S, Wilson L, Jordan MA. 2001. Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics. Proc Natl Acad Sci USA 98(20):11737-11742.
12. Gotlieb AI, May LM, Subrahmanyan L, Kalnins VI. 1991. Distribution of microtubule organizing centers in migrating sheets of endothelial cells. J Cell Biol 91(2 Pt 1):589-594.
13. Gundersen GG, Kalnoski MH, Bulinski JC. 1984. Distinct populations of microtubules: tyrosinated and nontyrosinated alpha tubulin are distributed differently in vivo. Cell 38(3):779-789.
14. Gundersen GG, Khawaja S, Bulinski JC. 1987. Postpolymerization detyrosination of alpha-tubulin: a mechanism for subcellular differentiation of microtubules. J Cell Biol 105(1):251-264.
15. Herbst RS, Khuri FR. 2003. Mode of action of docetaxel-a basis for combination with novel anticancer agents. Cancer Treat Rev 29(5):407-415.
16. Hotchkiss KA, Ashton AW, Mahmood R, Russell RG, Sparano JA, Schwartz EL. 2002. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center. Mol Cancer Ther 1(13):1191-2000.
17. Jordan MA. 2002. Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr Med Chem Anti-Cancer Agents 2:1-17.
18. Jordan MA, Wilson L. 1999. The use and action of drugs in analyzing mitosis. In: Rieder C, editor. Methods in Cell Biology. San Diego: Academic Press, Vol. 61. pp 267-295.
19. Jordan MA, Wilson L. 2004. Microtubules as a target for anticancer drugs. Nat Rev Cancer 4(4):253-265.
20. Jordan MA, Toso RJ, Thrower D, Wilson L. 1993. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 90:9552-9556.
21. Jordan MA, Wendell, K, Gardiner S, Derry B, Copp H, Wilson L. 1996. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 56:816-825.
22. Kamath K, Wilson L, Cabral F, Jordan MA. 2005. BetaIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability. J Biol Chem 280(13):12902-12907.
23. Kaverina I, Rottner K, Small JV. 1998. Targeting, capture, and stabilization of microtubules at early focal adhesions. J Cell Biol 142:181-190.
24. Kaverina I, Krylyshkina O, Small JV. 1999. Microtubule targeting of substrate contacts promotes their relaxation and dissociation. J Cell Biol 146(5):1033-1044.
25. Khawaja S, Gundersen GG, Bulinski JC. 1988. Enhanced stability of microtubules enriched in detyrosinated tubulin is not a direct function of detyrosination level. J Cell Biol 106(1):141-149.
26. Komlodi-Pasztor E, Sackett D, Wilkerson J, Fojo T. 2011. Mitosis is not a key target of microtubule agents in patient tumors. Nat Rev Clin Oncol 8(4):244-250.
27. Kreis TE. 1987. Microtubules containing detyrosinated tubulin are less dynamic. EMBO J 6(9):2597-2606.
28. Krendel M, Zenke FT, Bokoch GM. 2002. Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton. Nat Cell Biol 4:294-301.
29. Krylyshkina O, Kaverina I, Kranewitter W, Steffen W, Alonso MC, Cross RA, Small JV. 2002. Modulation of substrate adhesion dynamics via microtubule targeting requires kinesin-1. J Cell Biol 156(2):349-359.
30. Krylyshkina O, Anderson KI, Kaverina I, Upmann I, Manstein DJ, Small JV, Toomre DK. 2003. Nanometer targeting of microtubules to focal adhesions. J Cell Biol 161(5):853-859.
31. Kupfer A, Louvard D, Singer SJ. 1982. Polarization of the Golgi apparatus and the microtubule-organizing center in cultured fibroblasts at the edge of an experimental wound. Proc Natl Acad Sci USA 79:2603-2607.
32. LaPointe NE, Morfini G, Brady ST, Feinstein SC, Wilson L, Jordan MA. 2013. Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy. NeuroToxicology 37:231-239.
33. Liao G, Nagasaki T, Gundersen GG. 1995. Low concentrations of of nocodazole interfere with fibroblast locomotion without significantly affecting microtubule level: implications for the role of dynamic microtubules in cell locomotion. J Cell Sci 108:3473-3483.
34. Lu H, Murtagh J, Schwartz EL. 2006. The microtubule binding drug laulimalide inhibits vascular endothelial growth factor-induced human endothelial cell migration and is synergistic when combined with docetaxel (Taxotere). Mol Pharmacol 69:1207-1215.
35. Machicek M, Hodgson L, Welch, C, Elliott H, Pertz O, Nalbant P, Abell A, Johnson GL, Hahn KM, Danuser G. 2009. Coordination of Rho GTPase activities during cell protrusion. Nature 461:99-103.
36. Mitchison TJ, Kirschner M. 1984. Dynamic instability of microtubule growth. Nature 312:237-242.
37. Morgan C, Nigam Y. 2013. Naturally derived factors and their role in the promotion of angiogenesis for the healing of chronic wounds. Angiogenesis 16:493-502.
38. Murtagh J, Lu H, Schwartz EL. 2006. Taxotere-induced inhibition of human endothelial cell migration is a result of heat shock protein 90 degradation. Cancer Res 66(16):8192-8199.
39. Nagano M, Hoshino D, Koshikawa N, Akizawa T, Seiki M. 2012. Turnover of focal adhesions and cancer cell migration. Int J Cell Biol 2012:310616.
40. Palazzo AF, Gundersen GG. 2002. Microtubule-actin cross-talk at focal adhesions. Sci STKE 2002:pe31. http://www.stke.org/cgi/content/full/sigtrans;2002/139/pe31.
41. Panda D, Miller HP, Banerjee A, Luduena RF, Wilson L. 1994. Microtubule dynamics in vitro are regulated by the tubulin isotype composition. Proc Natl Acad Sci USA 91:11358-11362.
42. Pasquier E, Honore S, Pourroy B, Jordan MA, Lehmann M, Briand C, Braguer D. 2005. Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells. Cancer Res 65(6):2433-2440.
43. Ren XD, Kiosses WB, Schwartz MA. 1999. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton EMBO J. 18(3):578-585.
44. Ridley AJ. 2006. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol 16:522-529.
45. Rooney C, White G, Nazgiewicz A, Woodcock SA, Anderson KI, Ballestrem C, Malliri A. 2010. The Rac activator STEF (Tiam2) regulates cell migration by microtubule-mediated focal adhesion disassembly. EMBO Rep 11(4):292-298.
46. Rowinsky EK. 1997. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med 48:353-374.
47. Sastry SK, Burridge K. 2000. Focal adhesions: a nexus for intracellular signaling and cytoskeletal dynamics. Exp Cell Res 261:25-36.
48. Schiff PB, Horwitz SB. 1980. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 77:1561-1565.
49. Schulze E, Asai DJ, Bulinski JC, Kirschner M. 1987. Posttranslational modification and microtubule stability. J Cell Biol 105:2167-2177.
50. Small JV, Geiger B, Kaverina I, Bershadsky A. 2002. How do microtubules guide migrating cells? Nat Rev Mol Cell Biol 3:957-964.
51. Thadani-Mulero M, Nanus DM, Giannakakou P. 2012. Androgen receptor on the move: boarding the microtubule expressway to the nucleus. Cancer Res 72:4611-4615.
52. Umeshima H, Hirano T, Kengaku M. 2007. Microtubule-based nuclear movement occurs independently of centrosome positioning in migrating neurons. Proc Natl Acad Sci USA 104:16182-16187.
53. Watanabe T, Noritake J, Kaibuchi K. 2005. Regulation of microtubules in cell migration. Trends Cell Biol 15:76-83.
54. Waterman-Storer CM, Worthylake RA, Liu BP, Burridge K, Salmon ED. 1999. Microtubule growth activates Rac1 to promote lamellipodial protrusion in fibroblasts. Nat Cell Biol 1:45-50.
55. Webb DJ, Parsons JT, Horwitz AF. 2002. Adhesion assembly, disassembly and turnover in migrating cells-over and over and over again. Nat Cell Biol 4:E97-E100.
56. Webster DR, Gundersen GG, Bulinski JC, Borisy GG. 1987. Differential turnover of tyrosinated and detyrosinated microtubules. Proc Natl Acad Sci USA 84:9040-9044.
57. Yang H, Ganguly A, Cabral F. 2010. Inhibition of cell migration and cell division correlates with distinct effects of microtubule inhibiting drugs. J Biol Chem 285:32242-32250.
58. Yvon AM, Walker JW, Danowski B, Fagerstrom C, Khodjakov A, Wadsworth P. 2002. Centrosome reorientation in wound-edge cells is cell type specific. Mol Biol Cell 13(6):1871-1880.